V. Nienaber

1.8k total citations
32 papers, 1.3k citations indexed

About

V. Nienaber is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, V. Nienaber has authored 32 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in V. Nienaber's work include Peptidase Inhibition and Analysis (9 papers), Protease and Inhibitor Mechanisms (9 papers) and Enzyme Structure and Function (7 papers). V. Nienaber is often cited by papers focused on Peptidase Inhibition and Analysis (9 papers), Protease and Inhibitor Mechanisms (9 papers) and Enzyme Structure and Function (7 papers). V. Nienaber collaborates with scholars based in United States, Germany and United Kingdom. V. Nienaber's co-authors include Vincent L. Giranda, Jonathan Greer, Paul L. Richardson, Jennifer J. Bouska, Todd W. Rockway, John Badger, Jens J. Birktoft, Vandana Sridhar, Donald J. Davidson and Klaus Breddam and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Nature Biotechnology.

In The Last Decade

V. Nienaber

32 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Nienaber United States 19 779 251 221 214 204 32 1.3k
A.G. Pavlovsky United States 23 827 1.1× 129 0.5× 340 1.5× 232 1.1× 359 1.8× 37 1.5k
Susan Pav United States 12 960 1.2× 298 1.2× 94 0.4× 344 1.6× 251 1.2× 16 1.4k
Richard Cummings United States 26 1.2k 1.6× 121 0.5× 147 0.7× 353 1.6× 417 2.0× 52 2.4k
Christopher Pargellis United States 10 844 1.1× 235 0.9× 81 0.4× 300 1.4× 206 1.0× 12 1.2k
Walter H.J. Ward United Kingdom 18 985 1.3× 203 0.8× 68 0.3× 264 1.2× 298 1.5× 33 1.6k
Thilo Werner Germany 21 2.8k 3.5× 345 1.4× 103 0.5× 347 1.6× 326 1.6× 25 3.5k
James W. Janc United States 22 529 0.7× 98 0.4× 97 0.4× 287 1.3× 109 0.5× 51 1.1k
Paul E. Morin United States 17 990 1.3× 216 0.9× 43 0.2× 177 0.8× 226 1.1× 25 1.5k
Richard A. Pauptit United Kingdom 25 1.8k 2.3× 199 0.8× 226 1.0× 526 2.5× 558 2.7× 42 2.6k
Igor Mochalkin United States 18 510 0.7× 119 0.5× 107 0.5× 171 0.8× 88 0.4× 26 1.0k

Countries citing papers authored by V. Nienaber

Since Specialization
Citations

This map shows the geographic impact of V. Nienaber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Nienaber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Nienaber more than expected).

Fields of papers citing papers by V. Nienaber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Nienaber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Nienaber. The network helps show where V. Nienaber may publish in the future.

Co-authorship network of co-authors of V. Nienaber

This figure shows the co-authorship network connecting the top 25 collaborators of V. Nienaber. A scholar is included among the top collaborators of V. Nienaber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Nienaber. V. Nienaber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nienaber, V., Min Zhao, Philippe Y. Ayala, et al.. (2015). Novel covalent modification of human anaplastic lymphoma kinase (ALK) and potentiation of crizotinib-mediated inhibition of ALK activity by BNP7787. OncoTargets and Therapy. 375–375. 10 indexed citations
2.
Recht, Michael I., V. Nienaber, & Francisco Eduardo Torres. (2015). Fragment-Based Screening for Enzyme Inhibitors Using Calorimetry. Methods in enzymology on CD-ROM/Methods in enzymology. 567. 47–69. 6 indexed citations
3.
Recht, Michael I., Vandana Sridhar, John Badger, et al.. (2013). Identification and Optimization of PDE10A Inhibitors Using Fragment-Based Screening by Nanocalorimetry and X-ray Crystallography. SLAS DISCOVERY. 19(4). 497–507. 15 indexed citations
4.
Badger, John, B. Chie-Leon, Vandana Sridhar, et al.. (2012). Structure determination of LpxD from the lipopolysaccharide-synthesis pathway ofAcinetobacter baumannii. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 69(1). 6–9. 21 indexed citations
5.
Recht, Michael I., Vandana Sridhar, John Badger, et al.. (2012). Fragment-Based Screening for Inhibitors of PDE4A Using Enthalpy Arrays and X-ray Crystallography. SLAS DISCOVERY. 17(4). 469–480. 18 indexed citations
6.
Badger, John, B. Chie-Leon, Vandana Sridhar, et al.. (2012). Structure determination of LpxA from the lipopolysaccharide-synthesis pathway ofAcinetobacter baumannii. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 68(12). 1477–1481. 16 indexed citations
7.
Mezo, Adam R., Vandana Sridhar, John Badger, Paul Sakorafas, & V. Nienaber. (2010). X-ray Crystal Structures of Monomeric and Dimeric Peptide Inhibitors in Complex with the Human Neonatal Fc Receptor, FcRn. Journal of Biological Chemistry. 285(36). 27694–27701. 31 indexed citations
8.
Nienaber, V.. (2009). Start Small and Stay Small: Minimizing Attrition in the Clinic with a Focus on CNS Therapeutics. Current Topics in Medicinal Chemistry. 9(18). 1688–1704. 4 indexed citations
9.
Wendt, Michael, William J. McClellan, Todd W. Rockway, et al.. (2004). Interaction with the S1β-pocket of urokinase: 8-heterocycle substituted and 6,8-disubstituted 2-naphthamidine urokinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(12). 3063–3068. 24 indexed citations
10.
Atwell, S., J.M. Adams, John Badger, et al.. (2004). A Novel Mode of Gleevec Binding Is Revealed by the Structure of Spleen Tyrosine Kinase. Journal of Biological Chemistry. 279(53). 55827–55832. 161 indexed citations
11.
Bruncko, Milan, William J. McClellan, Michael Wendt, et al.. (2004). Naphthamidine urokinase plasminogen activator inhibitors with improved pharmacokinetic properties. Bioorganic & Medicinal Chemistry Letters. 15(1). 93–98. 19 indexed citations
12.
Rockway, Todd W., V. Nienaber, & Vincent L. Giranda. (2002). Inhibitors of the Protease Domain of Urokinase-Type Plasminogen Activator. Current Pharmaceutical Design. 8(28). 2541–2558. 49 indexed citations
13.
Nienaber, V. & Lawrence J. Berliner. (2000). Atomic Structures of Two Nitroxide Spin Labels Complexed with Human Thrombin: Comparison with Solution Studies. Journal of Protein Chemistry. 19(2). 129–137. 3 indexed citations
14.
Muchmore, Steven W., Jeffrey L. Olson, Ronald N. Jones, et al.. (2000). Automated Crystal Mounting and Data Collection for Protein Crystallography. Structure. 8(12). R243–R246. 54 indexed citations
15.
Nienaber, V., Jieyi Wang, Donald J. Davidson, & Jack Henkin. (2000). Re-engineering of Human Urokinase Provides a System for Structure-based Drug Design at High Resolution and Reveals a Novel Structural Subsite. Journal of Biological Chemistry. 275(10). 7239–7248. 43 indexed citations
16.
Nienaber, V., et al.. (2000). Thrombin Inhibitor Design: X-Ray and Solution Studies Provide a Novel P1 Determinant. Journal of Protein Chemistry. 19(4). 327–333. 4 indexed citations
17.
Nienaber, V., Donald J. Davidson, Rohinton Edalji, et al.. (2000). Structure-directed discovery of potent non-peptidic inhibitors of human urokinase that access a novel binding subsite. Structure. 8(5). 553–563. 46 indexed citations
18.
Nienaber, V., et al.. (2000). Discovering novel ligands for macromolecules using X-ray crystallographic screening. Nature Biotechnology. 18(10). 1105–1108. 235 indexed citations
19.
Nienaber, V., Klaus Breddam, & Jens J. Birktoft. (1993). A glutamic acid specific serine protease utilizes a novel histidine triad in substrate binding. Biochemistry. 32(43). 11469–11475. 58 indexed citations
20.
Nienaber, V., Sharon Young, Jens J. Birktoft, Deborah L. Higgins, & Lawrence J. Berliner. (1992). Conformational similarities between one-chain and two-chain tissue plasminogen activator (t-PA): implications to the activation mechanism on one-chain t-PA. Biochemistry. 31(15). 3852–3861. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A.G. Pavlovsky Breakdown of academic impact, for papers by Susan Pav Breakdown of academic impact, for papers by Richard Cummings Breakdown of academic impact, for papers by Christopher Pargellis Breakdown of academic impact, for papers by Walter H.J. Ward Breakdown of academic impact, for papers by Thilo Werner Breakdown of academic impact, for papers by James W. Janc Breakdown of academic impact, for papers by Paul E. Morin Breakdown of academic impact, for papers by Richard A. Pauptit Breakdown of academic impact, for papers by Igor Mochalkin
Rankless by CCL
2026